Verity Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,948
Closed -$1.61M 231
2024
Q1
$1.61M Sell
4,948
-260
-5% -$63.8K 0.9% 24
2023
Q4
$992K Buy
5,208
+773
+17% +$146K 0.63% 38
2023
Q3
$883K Buy
4,435
+214
+5% +$50.6K 0.65% 43
2023
Q2
$1.2M Sell
4,221
-590
-12% -$164K 0.89% 30
2023
Q1
$1.04M Buy
4,811
+328
+7% +$63.9K 0.62% 50
2022
Q4
$922K Buy
4,483
+3,478
+346% +$879K 0.79% 37
2022
Q3
$279K Buy
+1,005
New +$256K 0.29% 113

Other funds holding SWAV

Verity Asset Management's SWAV Position: Q2 2024 in Review

Verity Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,948 shares — an estimated $1.61M sold.

Verity Asset Management first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $1.61M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Verity Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Verity Asset Management sold 4,948 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.61M.
  • Verity Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Verity Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $1.61M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Verity Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.